Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Molecular Diagnostics: Page 2
CRISPR Therapeutics to present data from gene therapy programs at AHA Scientific Sessions
Biopharmaceutical company CRISPR Therapeutics will present preclinical data from its investigational gene therapy treatment programs for cardiovascular disease at the AHA Scientific Sessions 2023 in Philadelphia on November 11.
November 6, 2023
Blood test for biomarker offers route to affordable cancer screening
Researchers have developed a sensitive blood test for a highly specific biomarker of multiple common tumors, laying the groundwork for a product that could improve cancer screening.
November 6, 2023
Oxford Nanopore partners with Fabric Genomics on assessment of genetic disease in children
Oxford Nanopore Technologies and Fabric Genomics have teamed up to provide a sequencing analysis platform for neonatal and pediatric intensive care units.
November 1, 2023
Vertex Pharmaceuticals, CRISPR Therapeutics gene-editing therapy to undergo FDA advisory committee review
An FDA advisory committee is scheduled to meet on October 31 to discuss and make recommendations on Vertex Pharmaceuticals' and CRISPR Therapeutics’ CRISPR-Cas9 gene-editing-based therapy, exagamglogene autotemcel.
October 30, 2023
US ambassador visits NGS laboratory in India
There is growing bilateral cooperation in cancer research, prevention, control, and management, where leaders said they looked forward to the launch of the India-U.S. Cancer Dialogue.
October 30, 2023
Software reduces DANGER of CRISPR-Cas9 by shedding light on off-target edits
A new software can improve the safety and utility of CRISPR-Cas9 gene editing by detecting off-target changes and eliminating the need for reference genomes, according to a paper published in
Bioinformatics Advances
.
October 27, 2023
FDA to discuss phaseout enforcement discretion for LDTs
In relation to its proposed medical device rule targeting laboratory developed tests (LDTs), the U.S. Food and Drug Administration (FDA) will hold a webinar Tuesday, October 31, at 1 p.m. EST.
October 26, 2023
Polygenic risk score tests don’t meet expectations, U.K. study shows
Polygenic risk scores “perform poorly in screening and prediction of common disease,” failing to identify nearly 90% of patients who develop disease, according to a U.K. study.
October 26, 2023
Pharma companies back project to create largest African ancestry genomics research database
AstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.
October 25, 2023
Sanger Institute starts program to make biology as easy to engineer as software
The Wellcome Sanger Institute has begun a research program to empower scientists to engineer biology as easily as software, electronics, and cars.
October 23, 2023
Sophia Genetics, AstraZeneca, Memorial Sloan Kettering to collaborate on cancer test access
Sophia Genetics is collaborating with Memorial Sloan Kettering (MSK) Cancer Center and AstraZeneca to expand MSK's genomic sequencing tests to a global scale, with the aim of by providing more inclusive access to cancer testing worldwide.
October 20, 2023
AMP publishes best-practice recommendations for ctDNA assays
The Association for Molecular Pathology (AMP) has published its best-practice recommendations for validating, reporting, and publishing clinical circulating tumor DNA (ctDNA) assays.
October 17, 2023
Previous Page
Page 2 of 190
Next Page
